Pulmair Medical, Inc.
Clinical trials sponsored by Pulmair Medical, Inc., explained in plain language.
-
Artificial bronchus implant could offer new hope for severe emphysema patients
Disease control Recruiting nowThis study tests a new device called an implantable artificial bronchus (IAB) for people with severe emphysema or COPD. The goal is to see if the device can improve lung function and make breathing easier. About 60 adults will take part, and the main results will be checked 90 da…
Phase: NA • Sponsor: Pulmair Medical, Inc. • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New lung implant could ease breathing for emphysema patients
Disease control Recruiting nowThis study tests a new device called the IAB 50 Flex, an implant designed to help people with severe emphysema or COPD breathe easier. About 20 adults will receive the implant at two hospitals. The main goal is to check for serious side effects within 90 days.
Phase: NA • Sponsor: Pulmair Medical, Inc. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC